Jasper Therapeutics
JSPR----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Jasper Therapeutics(JSPR) predict that the EBIT is -10.95 M (+49.77%), Beat estimate;the EPS is -0.04 (+97.16%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B49.77%
-0.02B22.83%
+0.01B26.94%
EPSExceed expectations
-0.0497.16%
-0.522562.94%
+0.482534.22%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf